[ad_1]
U.S. regulator halted review of Moderna’s mRNA influenza application The Food and Drug Administration declined to accept Moderna’s application seeking approval for an mRNA based seasonal influenza vaccine, creating an unexpected roadblock for the company and broader interest in mRNA approaches to…
[ad_2]